Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $6.6 million.

  • Inspire Medical Systems' Change in Accured Expenses fell 5144.26% to $6.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.1 million, marking a year-over-year decrease of 5240.58%. This contributed to the annual value of $6.1 million for FY2025, which is 5240.58% down from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Change in Accured Expenses is $6.6 million, which was down 5144.26% from $10.8 million recorded in Q3 2025.
  • Over the past 5 years, Inspire Medical Systems' Change in Accured Expenses peaked at $13.7 million during Q4 2024, and registered a low of -$16.3 million during Q1 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was $4.4 million (2022), whereas its average is $2.2 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 656285.71% in 2021, then crashed by 12699.25% in 2022.
  • Over the past 5 years, Inspire Medical Systems' Change in Accured Expenses (Quarter) stood at $2.8 million in 2021, then soared by 73.57% to $4.9 million in 2022, then skyrocketed by 105.35% to $10.1 million in 2023, then surged by 35.38% to $13.7 million in 2024, then tumbled by 51.44% to $6.6 million in 2025.
  • Its Change in Accured Expenses was $6.6 million in Q4 2025, compared to $10.8 million in Q3 2025 and $5.0 million in Q2 2025.